Antiadrenergic actions of metiamide in cat thermoregulatory mechanisms
Burks, T.F.
Proceedings of the Western Pharmacology Society 19: 75-78
1976
ISSN/ISBN: 0083-8969 PMID: 11506 Document Number: 108659
Document emailed within 1 workday
Related Documents
Baldessarini, R.J.; Huston-Lyons, D.; Campbell, A.; Marsh, E.; Cohen, B.M. 1992: Do central antiadrenergic actions contribute to the atypical properties of clozapine? British Journal of Psychiatry. Supplement 1992(17): 12-16Gubitz, G.J.; Naylor, A.M.; Veale, W.L. 1987: Mechanism of vasopressin induced antipyresis: effects of cool and warm environments on the thermoregulatory actions of central vasopressin Proceedings of the Western Pharmacology Society 30: 253-257
Rothwell, N.J. 1990: Mechanisms of the pyrogenic actions of cytokines European Cytokine Network 1(4): 211-213
Kuroki, T.; Kato, R. 1986: On the mechanisms of actions of tumor promoters Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 2): 754-757
Adcock, I.M.; Ito, K. 2000: Molecular mechanisms of corticosteroid actions Monaldi Archives for Chest Disease 55(3): 256-266
Krieglstein, J. 1997: Mechanisms of neuroprotective drug actions Clinical Neuroscience 4(4): 184-193
Kushiku, K.; Ohba, M.; Mikagi, T.; Nuki, S.; Araki, Y.; Furukawa, T. 1989: Cardiovascular actions of buflomedil and possible mechanisms involved Arzneimittel-Forschung 39(6): 670-677
Fischer, H.D.; Schmidt, J.; Wustmann, C. 1984: On some mechanisms of antihypoxic actions of nootropic drugs Biomedica Biochimica Acta 43(4): 541-543
Kosano, H. 2008: Synthetic estrogens: some new pharmacological actions and mechanisms Nihon Rinsho. Japanese Journal of Clinical Medicine 66(1): 104-110
Nowak, G.; Szewczyk, B. 2002: Mechanisms contributing to antidepressant zinc actions Polish Journal of Pharmacology 54(6): 587-592
Satou, M. 2013: Molecular mechanisms involved in the diverse actions of ghrelin Seikagaku. Journal of Japanese Biochemical Society 85(7): 557-561
Bagdy, G. 1996: Studies on the sites and mechanisms of 5-HT1A receptor-mediated in vivo actions Acta Physiologica Hungarica 84(4): 399-401
Cowley, A.W. 1984: Assessment of the contributions of autoregulatory mechanisms to the antihypertensive actions of beta-adrenergic therapy Hypertension 6(2 Part 1): 137-139
Pilipchuk, N.S.; Kliachkin, L.M.; Protsiuk, R.G. 1989: Mechanisms of the therapeutic and damaging (side effects) actions of inhalation aerosol therapy Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 21-24
Nezhentsev, M.V.; Aleksandrov, S.I. 1994: The current concepts of the humoral mechanisms of the analgetic and antipyretic actions of acupuncture (a review of the literature) Likars'ka Sprava 1994(3-4): 39-42
Fox-Threlkeld, J.E.; Daniel, E.E.; Christinck, F.; Hruby, V.J.; Cipris, S.; Woskowska, Z. 1994: Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine Journal of Pharmacology and Experimental Therapeutics 268(2): 689-700
Hill, R.T. 1975: Neurochemical mechanisms in rat behavioral models of the euphorigenic and antihyperkinetic actions of psychomotor stimulant drugs Psychopharmacology Bulletin 11(3): 37-38
Prichard, B.N.; Graham, B.R.; Owens, C.W. 1999: Moxonidine: a new antiadrenergic antihypertensive agent Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 17(3): S41-S54
Bayer, B.L.; Förster, W. 1978: On a direct, antiadrenergic component of prostaglandin action in the heart Acta Biologica et Medica Germanica 37(5-6): 829-830
Cherry, K.J.; Ritchie, W.P. 1978: Influence of metiamide on "alkaline tide" Surgical Forum 29: 421-422